How many 6-K filings has Puretech Health PLC filed?

Puretech Health PLC (PTCHF) has 28 6-K (Foreign Current Report) filings on record, spanning Jan 2024 to Dec 2025.

What is a 6-K filing?

A 6-K is an SEC filing known as "Foreign Current Report." Current report filed by foreign private issuers for material events. Equivalent to the 8-K for domestic companies.

Where can I read Puretech Health PLC 6-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Puretech Health PLC 6-K filings, including risk assessment, sentiment analysis, and key financial figures.

Puretech Health PLC (PTCHF) — 6-K Filings

All 6-K filings from Puretech Health PLC. Browse 28 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (28)

6-K Filing — Dec 18, 2025
PureTech Health plc Reports AGM Results — Dec 10, 2025 Risk: low
PureTech Health plc announced the results of its Annual General Meeting held on June 16, 2025, via a press release on December 10, 2025. The company, listed on
PureTech Health plc Files 6-K Report — Aug 28, 2025 Risk: low
PureTech Health plc filed a Form 6-K on August 28, 2025, reporting for the period ending June 30, 2025. The company, based in Boston, MA, is a pharmaceutical pr
PureTech Health Announces Leadership Transition — Jul 16, 2025 Risk: low
PureTech Health plc announced a leadership transition on July 16, 2025, with the issuance of a press release titled "PureTech Announces Leadership Transition."
PureTech Health plc Director Resigns — Jul 8, 2025 Risk: low
On July 7, 2025, Raju Kucherlapati, Ph.D. resigned from his position as Chair of the board of directors of PureTech Health plc. He also served on the Research a
PureTech Health plc Reports 2025 AGM Results — Jun 16, 2025 Risk: low
PureTech Health plc announced the results of its 2025 Annual General Meeting on June 16, 2025. The company, listed on LSE and Nasdaq under ticker PRTC, confirme
PureTech Health plc Files Annual Results 6-K — Apr 30, 2025 Risk: low
PureTech Health plc filed a Form 6-K on April 30, 2025, to report its annual results for the year ended December 31, 2024. The company, listed on LSE and Nasdaq
PureTech Health Addresses Press Speculation — Apr 7, 2025 Risk: low
On April 7, 2025, PureTech Health plc issued a press release addressing recent press speculation. The company's statement aims to clarify its position amidst on
PureTech Health's LYT-100 Shows Promise in IPF Trial — Dec 16, 2024 Risk: medium
On December 16, 2024, PureTech Health plc announced positive results from its Phase 2b clinical trial for deupirfenidone (LYT-100) in treating idiopathic pulmon
PureTech Health forms Seaport Therapeutics with $100M — Oct 21, 2024 Risk: medium
On October 21, 2024, PureTech Health plc announced the formation of a new entity, Seaport Therapeutics. This new company will focus on developing treatments for
PureTech Health's KarXT Submitted to FDA for Schizophrenia — Sep 27, 2024 Risk: medium
On September 27, 2024, PureTech Health plc announced that its invented drug, KarXT, has been submitted for regulatory review by the FDA for the treatment of sch
PureTech Health plc Reports AGM Results — Aug 28, 2024 Risk: low
On August 28, 2024, PureTech Health plc announced the results of its Annual General Meeting. The company, listed on LSE and Nasdaq under ticker PRTC, confirmed
PureTech Health plc Files Mid-Year 6-K Report — Aug 28, 2024 Risk: low
PureTech Health plc filed a 6-K report for the period ending June 30, 2024. The filing includes financial data for the six months ended June 30, 2024, and compa
PureTech Health Appoints New Board Member — Aug 22, 2024 Risk: low
PureTech Health plc announced on August 22, 2024, the appointment of Michele Holcomb, PhD, to its Board of Directors. Dr. Holcomb brings extensive experience in
PureTech Health plc Announces Tender Offer Results — Jun 24, 2024 Risk: low
On June 24, 2024, PureTech Health plc announced the results of its tender offer, which was successful. The company also issued a press release regarding its co-
PureTech Health Announces Board Role Change — Jun 20, 2024 Risk: low
On June 20, 2024, PureTech Health plc announced a change in a board role. The company, listed on LSE and Nasdaq under ticker PRTC, issued a press release detail
PureTech Health plc Announces 2024 AGM Results — Jun 13, 2024 Risk: low
PureTech Health plc announced the results of its 2024 Annual General Meeting on June 13, 2024. The company, listed on LSE and Nasdaq under ticker PRTC, confirme
PureTech Health plc Announces General Meeting Results — Jun 6, 2024 Risk: low
On June 6, 2024, PureTech Health plc announced the results of its General Meeting. The company, listed on LSE and Nasdaq under the ticker PRTC, confirmed the pa
PureTech Health Proposes $100M Tender Offer at $25/Share — Jun 4, 2024 Risk: medium
PureTech Health plc announced on June 4, 2024, a proposed $100 million tender offer. The offer is set to commence on June 5, 2024, and will be made at a price o
PureTech Entity Akili Faces Nasdaq Delisting — May 29, 2024 Risk: medium
On May 29, 2024, PureTech Health plc announced that its founded entity, Akili Interactive, has received a delisting notice from the Nasdaq Stock Market. Akili I
PureTech Health Plans $100M Tender Offer at $2.50/Share — May 20, 2024 Risk: medium
PureTech Health plc announced on May 20, 2024, a proposed tender offer to purchase up to $100 million of its ordinary shares. The offer price is set at $2.50 pe
PureTech Health plc Reports 2023 Annual Results — Apr 25, 2024 Risk: low
PureTech Health plc announced its annual results for the year ended December 31, 2023, on April 25, 2024. The company, listed on LSE and Nasdaq under ticker PRT
PureTech Health Launches Seaport Therapeutics with $100M — Apr 9, 2024 Risk: medium
On April 9, 2024, PureTech Health plc announced the launch of Seaport Therapeutics, a new entity focused on developing treatments for rare diseases. The company
PureTech Health Proposes $100M Shareholder Capital Return — Mar 19, 2024 Risk: medium
On March 19, 2024, PureTech Health plc announced a proposed capital return of up to $100 million to its shareholders. The company, listed on LSE and Nasdaq unde
PureTech Health Announces Acquisition of Founded Entity — Mar 18, 2024 Risk: medium
On March 18, 2024, PureTech Health plc announced the acquisition of its founded entity, a significant development for the company. The press release details thi
PureTech Health Launches $50M Share Buyback Program — Mar 4, 2024 Risk: low
PureTech Health plc announced on May 9, 2022, the initiation of a $50 million share repurchase program. This program allows the company to buy back its own shar
PureTech Health Continues $50M Share Buyback Program — Feb 5, 2024
PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) announced on May 9, 2022, a $50 million share repurchase program for its ordinary shares. The program is split int
PureTech Continues $50M Share Buyback Program, Second Tranche Underway — Jan 4, 2024
PureTech Health plc announced on January 4, 2024, that it is continuing its $50 million share repurchase program, initially announced on May 9, 2022. The progra

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX